ライフサイエンスコーパス: coccidioidal

1 coccidioidomycosis who are nonresponsive to coccidioidal Ag and healthy nonimmune individuals in vit

2 se, monocyte-derived DCs were generated from coccidioidal Ag nonresponsive patients with disseminated

3 ealthy nonimmune individuals pulsed with the coccidioidal Ag preparation T27K induced lymphocyte prol

4 duals in vitro; 2) DCs can be used to screen coccidioidal Ags as candidates for human vaccine develop

5 man and mouse sera prior to the detection of coccidioidal antibodies.

6 ctivity was studied by using sera containing coccidioidal antibodies.

7 th human, canine, and equine sera containing coccidioidal antibody.

8 Subunits of a proline-rich coccidioidal antigen (Ag2/PRA) of Coccidioides immitis w

9 Using the coccidioidal antigen preparation T27K and multiparametri

10 ose is the predominant monosaccharide in the coccidioidal antigen preparation T27K.

11 When incubated in vitro with a coccidioidal antigen preparation, cells from both BAL fl

12 It was demonstrated that DCs pulsed with the coccidioidal antigen preparation, toluene spherule lysat

13 uclear cells (PBMCs) were incubated with the coccidioidal antigen T27K in vitro, and cellular immunol

14 clear cells (PBMC) after incubation with the coccidioidal antigen toluene spherule lysate (TSL) from

15 responses of PBMC from various donors to the coccidioidal antigen toluene spherule lysate (TSL).

16 IL-4, IL-6, and IL-17A in the presence of a coccidioidal antigen, indicating that IL-10 suppresses T

17 mitis can specifically prime lymphocytes for coccidioidal antigens and that the response generated by

18 xpression system is a useful tool to produce coccidioidal antigens for use as diagnostic antigens.

19 elded reactions comparable to those of crude coccidioidal antigens in conventional CF, IDCF, and enzy

20 The cDNA encoding the coccidioidal aspartyl proteinase open reading frame was

21 The coccidioidal cDNA encoding the proteinase was amplified

22 pherules and from hyphae and shown to be the coccidioidal complement fixation (CF) and immunodiffusio

23 The coccidioidal complement fixation (CF) antigen has been c

24 Patients with mediastinitis or elevated coccidioidal complement fixation titers require longer h

25 s patients]; P < .01) and those with maximum coccidioidal complement fixing antibody titers >/=1:128

26 cted in 53 (91.4%) of 58 patients whose anti-coccidioidal complement-fixing (CF) antibodies were dete

27 ells (PBMC) from individuals with or without coccidioidal delayed-type hypersensitivity (DTH), we exa

28 bed to date have provided full protection to coccidioidal disease-susceptible BALB/c mice.

29 oduct was visualized when 10 fg of exogenous coccidioidal DNA was subjected to amplification.

30 in vitro TSL response is highly dependent on coccidioidal DTH.

31 clusters and IL-10 in association with human coccidioidal granulomata and suggests that down-regulati

32 explore this further, pulmonary necrotizing coccidioidal granulomata were examined using immunohisto

33 cellular immune response is occurring within coccidioidal granulomata.

34 significantly less than that from 7 healthy, coccidioidal-immune subjects (P = .015).

35 in the peripheral blood of individuals with coccidioidal immunity and suggest a model for the in vit

36 f dendritic cells (DCs) in the initiation of coccidioidal immunity in nonimmune individuals.

37 taking azole prophylaxis and had no further coccidioidal infection after transplantation.

38 ue damage, which exacerbates the severity of coccidioidal infection and enhances the virulence of thi

39 Previously latent coccidioidal infection can reactivate after transplantat

40 for screening, treatment, and prevention of coccidioidal infection in the lung transplant candidate.

41 n relatively high concentrations at sites of coccidioidal infection in the lungs of mice.

42 Coccidioidal infection is overcome by the development of

43 Primary subcutaneous coccidioidal infection is rare but has been reported to

44 or CSF antibody, particularly if the primary coccidioidal infection is unrecognized.

45 f C. immitis, vaccine development to prevent coccidioidal infection, a better understanding of the so

46 erum and serum from a patient with confirmed coccidioidal infection, an immunodiffusion test for CF a

47 detected in sera of patients with confirmed coccidioidal infection, and the highest titers of antibo

48 be reactive with antibody from patients with coccidioidal infection, elicits a potent proliferative r

49 Because lungs are the primary site of coccidioidal infection, lung transplant recipients in en

50 ich has been used for serodiagnosis of early coccidioidal infection.

51 d cellular immune responses in patients with coccidioidal infection.

52 s, standard testing gains in sensitivity for coccidioidal infection.

53 l role as a pathogenicity determinant during coccidioidal infections and contributes to the ability o

54 oles further revolutionized the treatment of coccidioidal infections.

55 Eight other coccidioidal isolates, selected for diversity in geograp

56 Diagnosing coccidioidal meningitis (CM) can be problematic owing to

57 Coccidioidal meningitis (CM) has high morbidity, and adj

58 Coccidioidal meningitis (CM) is a devastating complicati

59 Coccidioidal meningitis (CM), a common cause of chronic

60 3-kDa antibodies is a sensitive indicator of coccidioidal meningitis and of its clinical course.

61 1:80 in only 1 (1.4%) of 73 patients without coccidioidal meningitis but in 74 (71.8%) of 103 with me

62 Coccidioidal meningitis is lethal in humans.

63 Data were gathered on patients with coccidioidal meningitis who had successfully responded t

64 Patients who develop chronic coccidioidal pneumonia or extrapulmonary infection often

65 tion of the inserted gene in the constructed coccidioidal protein expression vector (pCE).

66 , we developed a novel system to overexpress coccidioidal proteins in a nonpathogenic fungus, Uncinoc

67 ystem (CNS) involvement are cryptococcal and coccidioidal, so CSF BG screening can be useful in menin

68 We identified 9 cases of coccidioidal tenosynovitis of the hand and wrist at our

69 ly searched for the records of patients with coccidioidal tenosynovitis of the hand and wrist at our

70 was to examine the outcomes of patients with coccidioidal tenosynovitis of the hand and wrist.

71 A treatment strategy for coccidioidal tenosynovitis should focus on long-term adm

72 T cells from mice immunized with whole-cell coccidioidal vaccines.